Randolph, NJ, United States of America

Jie Xiao



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jie Xiao - Innovator in Pharmaceutical Compositions

Introduction

Jie Xiao is a notable inventor based in Randolph, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral delivery systems for pharmacologically active agents. His innovative work has led to the creation of compositions that enhance the bioavailability of important therapeutic agents.

Latest Patents

Jie Xiao holds 1 patent for his invention titled "Pharmaceutical compositions for the oral delivery of pharmacologically active agents." This patent describes solid pharmaceutical compositions that are suitable for the oral delivery of pharmacologically active agents, such as peptides. The compositions include a therapeutically effective amount of a pharmacologically active agent, a crospovidone or povidone, and a delivery agent. These formulations provide excellent oral bioavailability, particularly for calcitonin, making them valuable in therapeutic applications.

Career Highlights

Throughout his career, Jie Xiao has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.

Collaborations

Jie Xiao has collaborated with several professionals in his field, including Joseph Ault and Moise Azria. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Jie Xiao's innovative work in pharmaceutical compositions has the potential to significantly impact the delivery of therapeutic agents. His contributions to the field exemplify the importance of research and development in enhancing drug efficacy and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…